
TY  - JOUR
TI  - Paediatric SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_12.x
DO  - doi:10.1111/j.1440-1843.2011.01937_12.x
SP  - 69
EP  - 73
PY  - 2011
ER  - 

TY  - JOUR
TI  - Pulmonary Physiology & Sleep SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_13.x
DO  - doi:10.1111/j.1440-1843.2011.01937_13.x
SP  - 73
EP  - 77
PY  - 2011
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG: Poster Session 2
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_2.x
DO  - doi:10.1111/j.1440-1843.2011.01937_2.x
SP  - 40
EP  - 43
PY  - 2011
ER  - 

TY  - JOUR
TI  - Interventional Pulmonology SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_8.x
DO  - doi:10.1111/j.1440-1843.2011.01937_8.x
SP  - 59
EP  - 62
PY  - 2011
ER  - 

TY  - JOUR
TI  - Physiotherapy SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_14.x
DO  - doi:10.1111/j.1440-1843.2011.01937_14.x
SP  - 77
EP  - 80
PY  - 2011
ER  - 

TY  - JOUR
TI  - COPD SIG: Poster Session 1
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_5.x
DO  - doi:10.1111/j.1440-1843.2011.01937_5.x
SP  - 50
EP  - 52
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Microcirculation
JA  - Microcirculation
VL  - 22
IS  - 8
SN  - 1073-9688
UR  - https://doi.org/10.1111/micc.12212
DO  - doi:10.1111/micc.12212
SP  - 753
EP  - 781
PY  - 2015
ER  - 

AU  - Quirolo, Keith
AU  - Vichinsky, Elliott
C7  - pp. 126-143
TI  - Sickle cell anemia, thalassemia, and congenital hemolytic anemias
SN  - 9781119012993
UR  - https://doi.org/10.1002/9781119013020.ch11
DO  - doi:10.1002/9781119013020.ch11
SP  - 126-143
KW  - anemia
KW  - congenital hemolytic anemia
KW  - hereditary elliptocytosis
KW  - malaria
KW  - nucleicacid amplification technology
KW  - red cell transfusion
KW  - sickle cell anemia
KW  - thalassemia
PY  - 2015
AB  - Summary Sickle cell diseases or the thalassemias are the most prevalent monogenetic disorders worldwide. In sickle cell disease, transfusions prevent and/or treat complications and ameliorate anemia. In the thalassemias, transfusion prevents the anemia associated with decreased or absent hemoglobin production. The human blood groups are either receptors for the malarial parasite or are involved in the rosetting of red cells infected with the malarial parasite. Alpha thalassemia is the most common single-gene disease in the world. Red cell transfusion has been a therapy for sickle cell disease for decades, becoming more prevalent since the institution of nucleic acid amplification technology (NAT), leukoreduction, and routine red cell phenotyping for transfusion. Hereditary elliptocytosis (HE) has a worldwide distribution, but it is more common in malarial areas. The congenital hemolytic anemias are a diverse group of blood diseases that generally do not require red cell transfusion.
ER  - 

TY  - JOUR
TI  - Keyword Index
JO  - The FEBS Journal
VL  - 275
IS  - s1
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1742-4658.2008.06450.x
DO  - doi:10.1111/j.1742-4658.2008.06450.x
SP  - 489
EP  - 506
PY  - 2008
ER  - 

TY  - JOUR
TI  - Cell Biology/Immunology SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_4.x
DO  - doi:10.1111/j.1440-1843.2011.01937_4.x
SP  - 47
EP  - 50
PY  - 2011
ER  - 

TY  - JOUR
TI  - Cystic Fibrosis SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_7.x
DO  - doi:10.1111/j.1440-1843.2011.01937_7.x
SP  - 55
EP  - 58
PY  - 2011
ER  - 

TY  - JOUR
TI  - Respiratory Infectious Diseases SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_15.x
DO  - doi:10.1111/j.1440-1843.2011.01937_15.x
SP  - 80
EP  - 84
PY  - 2011
ER  - 

C7  - pp. 745-789
TI  - Subject Index
SN  - 9780470695111
UR  - https://doi.org/10.1002/9781118675410.indsub
DO  - doi:10.1002/9781118675410.indsub
SP  - 745-789
PY  - 2011
ER  - 

TY  - JOUR
TI  - Basic and clinical science posters
JO  - Diabetic Medicine
JA  - Diabet. Med.
VL  - 31
IS  - s1
SN  - 9780470695111
UR  - https://doi.org/10.1111/dme.12378_1
DO  - doi:10.1111/dme.12378_1
SP  - 28
EP  - 73
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Reproduction in Domestic Animals
JA  - Reprod Dom Anim
VL  - 52
IS  - S1
SN  - 9780470695111
UR  - https://doi.org/10.1111/rda.12909
DO  - doi:10.1111/rda.12909
SP  - 5
EP  - 59
PY  - 2017
ER  - 

TY  - JOUR
TI  - Jahreskalender
JO  - Nachrichten aus der Chemie
JA  - Nachr. Chem.
VL  - 61
IS  - 1
SN  - 9780470695111
UR  - https://doi.org/10.1002/nadc.201390025
DO  - doi:10.1002/nadc.201390025
SP  - 68
EP  - 80
PY  - 2013
ER  - 

TY  - JOUR
TI  - Table_of_Contents_2019
JO  - Movement Disorders Clinical Practice
JA  - Mov Disord Clin Pract
VL  - 6
IS  - S1
SN  - 9780470695111
UR  - https://doi.org/10.1002/mdc3.12745
DO  - doi:10.1002/mdc3.12745
SP  - S1
EP  - S10
PY  - 2019
ER  - 

TY  - JOUR
AU  - Uno, Yota
AU  - Coyle, Joseph T.
TI  - Glutamate hypothesis in schizophrenia
JO  - Psychiatry and Clinical Neurosciences
JA  - Psychiatry Clin. Neurosci.
VL  - 73
IS  - 5
SN  - 9780470695111
UR  - https://doi.org/10.1111/pcn.12823
DO  - doi:10.1111/pcn.12823
SP  - 204
EP  - 215
KW  - D-serine
KW  - glutamate
KW  - N-methyl-d-aspartate receptor
KW  - schizophrenia
KW  - serine racemase
PY  - 2019
AB  - Schizophrenia is a chronic and severe psychiatric disorder that has profound impact on an individual?s life and on society. Thus, developing more effective therapeutic interventions is essential. Over the past quarter-century, an abundance of evidence from pharmacologic challenges, post-mortem studies, brain imaging, and genetic studies supports the role of glutamatergic dysregulation in the pathophysiology of schizophrenia, and the results of recent randomized clinical trials based on this evidence have yielded promising results. In this article, we review the evidence that alterations in glutamatergic neurotransmission, especially focusing on the N-methyl-d-aspartate receptor (NMDAR) function, may be a critical causative feature of schizophrenia, how this contributes to pathologic circuit function in the brain, and how these insights are revealing whole new avenues for treatment development that could reduce treatment-resistant symptoms, which account for persistent disability.
ER  - 

TY  - JOUR
TI  - Free Communications
JO  - Transplant International
VL  - 25
IS  - s2
SN  - 9780470695111
UR  - https://doi.org/10.1111/tri.12030
DO  - doi:10.1111/tri.12030
SP  - 21
EP  - 46
PY  - 2012
ER  - 

TY  - JOUR
AU  - Boularaoui, Selwa Mokhtar
AU  - Abdel-Raouf, Khaled M.A.
AU  - Alwahab, Noaf Salah Ali
AU  - Kondash, Megan E.
AU  - Truskey, George A.
AU  - Teo, Jeremy Choon Meng
AU  - Christoforou, Nicolas
C8  - TERM-16-0256.R2
TI  - Efficient transdifferentiation of human dermal fibroblasts into skeletal muscle
JO  - Journal of Tissue Engineering and Regenerative Medicine
JA  - J Tissue Eng Regen Med
VL  - 12
IS  - 2
SN  - 9780470695111
UR  - https://doi.org/10.1002/term.2415
DO  - doi:10.1002/term.2415
SP  - e918
EP  - e936
KW  - skeletal muscle
KW  - transdifferentiation
KW  - extracellular matrix
KW  - collagen type I
KW  - TGFÎ²/activin
KW  - WNT
KW  - receptor tyrosine kinase
PY  - 2018
AB  - Abstract Skeletal muscle holds significant regenerative potential but is incapable of restoring tissue loss caused by severe injury, congenital defects or tumour ablation. Consequently, skeletal muscle models are being developed to study human pathophysiology and regeneration. Their physiological accuracy, however, is hampered by the lack of an easily accessible human cell source that is readily expandable and capable of efficient differentiation. MYOD1, a master gene regulator, induces transdifferentiation of a variety of cell types into skeletal muscle, although inefficiently in human cells. Here we used MYOD1 to establish its capacity to induce skeletal muscle transdifferentiation of human dermal fibroblasts under baseline conditions. We found significant transdifferentiation improvement via transforming growth factor-?/activin signalling inhibition, canonical WNT signalling activation, receptor tyrosine kinase binding and collagen type I utilization. Mechanistically, manipulation of individual signalling pathways modulated the transdifferentiation process via myoblast proliferation, lowering the transdifferentiation threshold and inducing cell fusion. Overall, we used transdifferentiation to achieve the robust derivation of human skeletal myotubes and have described the signalling pathways and mechanisms regulating this process. Copyright ? 2017 John Wiley & Sons, Ltd.
ER  - 
